Page last updated: 2024-10-23

bendroflumethiazide and Cancer of Skin

bendroflumethiazide has been researched along with Cancer of Skin in 1 studies

Bendroflumethiazide: A thiazide diuretic with actions and uses similar to those of HYDROCHLOROTHIAZIDE. It has been used in the treatment of familial hyperkalemia, hypertension, edema, and urinary tract disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p810)
bendroflumethiazide : A sulfonamide consisting of 7-sulfamoyl-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide in which the hydrogen at position 6 is substituted by a trifluoromethyl group and that at position 3 is substituted by a benzyl group.

Research Excerpts

ExcerptRelevanceReference
"Hydrochlorothiazide is associated with an increased risk for NMSC (especially SCC) and melanoma in non-Asian countries, whereas bendroflumethiazide and indapamide are not associated with a meaningful risk for skin cancers."5.22Associations of thiazide use with skin cancers: a systematic review and meta-analysis. ( Chen, YH; Chi, CC; Hung, MJ; Lai, CC; Lai, EC; Shao, SC, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Shao, SC1
Lai, CC1
Chen, YH1
Lai, EC1
Hung, MJ1
Chi, CC1

Reviews

1 review available for bendroflumethiazide and Cancer of Skin

ArticleYear
Associations of thiazide use with skin cancers: a systematic review and meta-analysis.
    BMC medicine, 2022, 07-07, Volume: 20, Issue:1

    Topics: Bendroflumethiazide; Carcinoma, Squamous Cell; Humans; Hydrochlorothiazide; Indapamide; Melanoma; Sk

2022